1. Home
  2. CVCO vs LGND Comparison

CVCO vs LGND Comparison

Compare CVCO & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CVCO

Cavco Industries Inc. When Issued

HOLD

Current Price

$597.07

Market Cap

4.6B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$189.25

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVCO
LGND
Founded
1965
1987
Country
United States
United States
Employees
N/A
68
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.9B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
CVCO
LGND
Price
$597.07
$189.25
Analyst Decision
Hold
Strong Buy
Analyst Count
1
8
Target Price
$550.00
$144.71
AVG Volume (30 Days)
147.8K
139.7K
Earning Date
01-29-2026
08-05-2025
Dividend Yield
N/A
N/A
EPS Growth
37.54
N/A
EPS
24.29
N/A
Revenue
$2,143,782,000.00
$181,488,000.00
Revenue This Year
$15.26
$18.41
Revenue Next Year
$8.18
$18.87
P/E Ratio
$24.58
N/A
Revenue Growth
15.76
53.40
52 Week Low
$393.53
$81.74
52 Week High
$614.11
$129.90

Technical Indicators

Market Signals
Indicator
CVCO
LGND
Relative Strength Index (RSI) 58.40 45.58
Support Level $550.99 $179.65
Resistance Level $608.06 $192.44
Average True Range (ATR) 25.63 6.57
MACD 0.89 -2.06
Stochastic Oscillator 73.04 31.70

Price Performance

Historical Comparison
CVCO
LGND

About CVCO Cavco Industries Inc. When Issued

Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: